Cargando…
Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults
BACKGROUND: Athletes are increasingly exploring ways to enhance their physical performance. Increasing blood flow to the working tissues through endothelium-dependent vasodilation is one factor athletes use to realize these results. Sports supplements such as pre-workouts tout this benefit; however,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041093/ https://www.ncbi.nlm.nih.gov/pubmed/32093766 http://dx.doi.org/10.1186/s12970-020-00343-y |
_version_ | 1783501103293267968 |
---|---|
author | Rogers, Jeffrey M. Gills, Joshua Gray, Michelle |
author_facet | Rogers, Jeffrey M. Gills, Joshua Gray, Michelle |
author_sort | Rogers, Jeffrey M. |
collection | PubMed |
description | BACKGROUND: Athletes are increasingly exploring ways to enhance their physical performance. Increasing blood flow to the working tissues through endothelium-dependent vasodilation is one factor athletes use to realize these results. Sports supplements such as pre-workouts tout this benefit; however, many have not been tested under laboratory conditions to examine the effects of commonly used supplements on vasodilation. Two popular supplements are Nitrosigine® and citrulline malate (CM). Thus, the purpose of this experiment was to determine the effects of Nitrosigine and CM on vasodilation using ultrasound and flow mediated dilation (FMD). METHODS: Healthy, normotensive, and physically active male (n = 16) and female (n = 8) young adults participated in the present investigation. We utilized a randomized, double-blind, within-subjects design where participants reported for three trials, each preceded by a 7-day washout period. Baseline FMD measurement was obtained for each visit, followed by consumption of one clinical dose CM (8 g), Nitrosigine (1.5 g), or dextrose placebo (8 g). Following a 60-min digestion period, FMD was repeated. Supplementation order was randomized controlling for potential order effects. RESULTS: Repeated measures ANOVA yielded a significant supplement (3) x time (2) effect (p < .001), such that Nitrosigine and CM yielded a greater improvement in FMD response than placebo. After supplementation, Nitrosigine and CM increased FMD by 31 and 34%, respectively, compared to a decrease of 2% during the placebo trial. After allometric scaling of the FMD values, supplement x time effect remained significant (p = .001) and changes were similar to non-scaled results. Nitrosigine (23%) and CM (25%) generated significantly greater allometric scaled FMD values when compared to the placebo trial (0.60%). DISCUSSION: Both Nitrisigine and CM increased endothelial-dependent vasodilation as measured by a change in FMD. Increased vasodilation leads to an increase in skeletal muscle blood flow resulting in potential improvements in exercise performance. |
format | Online Article Text |
id | pubmed-7041093 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70410932020-03-02 Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults Rogers, Jeffrey M. Gills, Joshua Gray, Michelle J Int Soc Sports Nutr Research Article BACKGROUND: Athletes are increasingly exploring ways to enhance their physical performance. Increasing blood flow to the working tissues through endothelium-dependent vasodilation is one factor athletes use to realize these results. Sports supplements such as pre-workouts tout this benefit; however, many have not been tested under laboratory conditions to examine the effects of commonly used supplements on vasodilation. Two popular supplements are Nitrosigine® and citrulline malate (CM). Thus, the purpose of this experiment was to determine the effects of Nitrosigine and CM on vasodilation using ultrasound and flow mediated dilation (FMD). METHODS: Healthy, normotensive, and physically active male (n = 16) and female (n = 8) young adults participated in the present investigation. We utilized a randomized, double-blind, within-subjects design where participants reported for three trials, each preceded by a 7-day washout period. Baseline FMD measurement was obtained for each visit, followed by consumption of one clinical dose CM (8 g), Nitrosigine (1.5 g), or dextrose placebo (8 g). Following a 60-min digestion period, FMD was repeated. Supplementation order was randomized controlling for potential order effects. RESULTS: Repeated measures ANOVA yielded a significant supplement (3) x time (2) effect (p < .001), such that Nitrosigine and CM yielded a greater improvement in FMD response than placebo. After supplementation, Nitrosigine and CM increased FMD by 31 and 34%, respectively, compared to a decrease of 2% during the placebo trial. After allometric scaling of the FMD values, supplement x time effect remained significant (p = .001) and changes were similar to non-scaled results. Nitrosigine (23%) and CM (25%) generated significantly greater allometric scaled FMD values when compared to the placebo trial (0.60%). DISCUSSION: Both Nitrisigine and CM increased endothelial-dependent vasodilation as measured by a change in FMD. Increased vasodilation leads to an increase in skeletal muscle blood flow resulting in potential improvements in exercise performance. BioMed Central 2020-02-24 /pmc/articles/PMC7041093/ /pubmed/32093766 http://dx.doi.org/10.1186/s12970-020-00343-y Text en © The Author(s) 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Rogers, Jeffrey M. Gills, Joshua Gray, Michelle Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults |
title | Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults |
title_full | Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults |
title_fullStr | Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults |
title_full_unstemmed | Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults |
title_short | Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults |
title_sort | acute effects of nitrosigine® and citrulline malate on vasodilation in young adults |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041093/ https://www.ncbi.nlm.nih.gov/pubmed/32093766 http://dx.doi.org/10.1186/s12970-020-00343-y |
work_keys_str_mv | AT rogersjeffreym acuteeffectsofnitrosigineandcitrullinemalateonvasodilationinyoungadults AT gillsjoshua acuteeffectsofnitrosigineandcitrullinemalateonvasodilationinyoungadults AT graymichelle acuteeffectsofnitrosigineandcitrullinemalateonvasodilationinyoungadults |